News Industry News Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure July 23, 2019
News Industry News Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries April 16, 2019
News Industry News Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes August 26, 2015
News Industry News New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks January 08, 2013
News Industry News Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay May 18, 2011